A Phase 2b/3 randomized, double-blind, placebo-controlled, parallel group, multicentre study investigating the efficacy and safety of JNJ54861911 in subjects who are asymptomatic at risk for develo... (2016–2022)

Grant type:
Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Janssen-Cilag Pty Limited (Janssen-Cilag Australia)